J&J prospects for gold in array of new deals
Johnson & Johnson Innovation LLC is opening 2017 with a blizzard of new deals, touching depression, cancer, diabetes, obesity and more. Highlights among the deals include an option to buy Bird Rock Bio Inc. following a phase I readout for its non-alcoholic steatohepatitis candidate, namacizumab.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST